Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Ameliorative effect of Cassia singueana extract against acute ketamine induced cognitive impairment in murine models of schizophrenia

View through CrossRef
Introduction: In the quest for search of novel pharmacotherapy from medicinal plants for psychiatric disorders, it has progressed appreciably for the past few decades and their therapeutic potential has been evaluated in a variety of murine models. Cassia singueana Del. is a commonly used medicinal plant in Nigeria for management of insanity and as lactation enhancer. Aim: The main aim of this study was to evaluate the cognitive potential of Cassia singueana extract against ketamine-induced cognitive impairment in mice. Methods: The phytochemicals and elemental minerals present in the extract were determined using standard protocol and antioxidant potential of the extract was evaluated using TBA-TCAA protocols, while its oral median lethal dose (LD50) in mice was estimated by OECD protocol. The effect of Cassia singueana extract (100, 200 and 400 mg/kg) on neurobehavioral deficit was evaluated in mice using behavioural paradigms: Y- maze, novel object recognition, forced swim test, open field test and catalepsy test. Results: The phytochemical constituents of Cassia singueana were alkaloids, cardiac glycosides, tannins, flavonoids, saponins, steroids and triterpenes. The extract also significantly decreased the level of MDA and increased the level of SOD and GSH. Oral LD50 was estimated to be >5000 mg/kg. Cassia singueana extract significantly (P< 0.05) increased the exploration time of novel object and percentage recognition index during the retention phase of the NORT. In Y-maze test, the extract significantly (p<0.05) increased the number of actual alternation and the percentage spontaneous alternation. It also significantly (p<0.05) decreased the duration of immobility in forced swim test. The extract also significantly (p<0.05) increased the number of central and peripheral square cross in open field. The extract also did not prolong the duration of catalepsy induced by haloperidol in glass bar test. Conclusion: Cassia singueana extract contained phytochemicals that could ameliorate cognitive impairment and negative symptoms of schizophrenics.
Title: Ameliorative effect of Cassia singueana extract against acute ketamine induced cognitive impairment in murine models of schizophrenia
Description:
Introduction: In the quest for search of novel pharmacotherapy from medicinal plants for psychiatric disorders, it has progressed appreciably for the past few decades and their therapeutic potential has been evaluated in a variety of murine models.
Cassia singueana Del.
is a commonly used medicinal plant in Nigeria for management of insanity and as lactation enhancer.
Aim: The main aim of this study was to evaluate the cognitive potential of Cassia singueana extract against ketamine-induced cognitive impairment in mice.
Methods: The phytochemicals and elemental minerals present in the extract were determined using standard protocol and antioxidant potential of the extract was evaluated using TBA-TCAA protocols, while its oral median lethal dose (LD50) in mice was estimated by OECD protocol.
The effect of Cassia singueana extract (100, 200 and 400 mg/kg) on neurobehavioral deficit was evaluated in mice using behavioural paradigms: Y- maze, novel object recognition, forced swim test, open field test and catalepsy test.
Results: The phytochemical constituents of Cassia singueana were alkaloids, cardiac glycosides, tannins, flavonoids, saponins, steroids and triterpenes.
The extract also significantly decreased the level of MDA and increased the level of SOD and GSH.
Oral LD50 was estimated to be >5000 mg/kg.
Cassia singueana extract significantly (P< 0.
05) increased the exploration time of novel object and percentage recognition index during the retention phase of the NORT.
In Y-maze test, the extract significantly (p<0.
05) increased the number of actual alternation and the percentage spontaneous alternation.
It also significantly (p<0.
05) decreased the duration of immobility in forced swim test.
The extract also significantly (p<0.
05) increased the number of central and peripheral square cross in open field.
The extract also did not prolong the duration of catalepsy induced by haloperidol in glass bar test.
Conclusion: Cassia singueana extract contained phytochemicals that could ameliorate cognitive impairment and negative symptoms of schizophrenics.

Related Results

Vegetable Tannins as Chrome-Free Leather Tanning
Vegetable Tannins as Chrome-Free Leather Tanning
The purpose of this study is to replace chrome tannins with ecofriendly vegetable tannins as an alternative solution to prevent the public health and the environmental pollution. V...
Combined Low Dose of Ketamine and Social Isolation: A Possible Model of Induced Chronic Schizophrenia-Like Symptoms in Male Albino Rats
Combined Low Dose of Ketamine and Social Isolation: A Possible Model of Induced Chronic Schizophrenia-Like Symptoms in Male Albino Rats
While animal models for schizophrenia, ranging from pharmacological models to lesions and genetic models, are available, they usually mimic only the positive symptoms of this disor...
Lasting s-ketamine block of spreading depolarizations in subarachnoid hemorrhage: a retrospective cohort study
Lasting s-ketamine block of spreading depolarizations in subarachnoid hemorrhage: a retrospective cohort study
Abstract Objective Spreading depolarizations (SD) are characterized by breakdown of transmembrane ion gradients and excitotoxicity. Experimentally, ...
Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature
Recurrent Serotonin Syndrome After Ketamine-assisted Electroconvulsive Therapy: A Case Report and Review of the Literature
Serotonin (5-HT) syndrome (SS) consists of changes in mental status as well as autonomic and neuromuscular changes. Though not well understood, serotonergic pathways have been impl...
Ketamine for the Critically Ill: Case Series and Clinical Reflections
Ketamine for the Critically Ill: Case Series and Clinical Reflections
Background: Considering its unique pharmacology, ketamine has become a subject of interest for various therapeutic applications in intensive care as a dissociative anesthetic agent...
Oral Administration of Injectable Ketamine During Burn Wound Dressing Changes
Oral Administration of Injectable Ketamine During Burn Wound Dressing Changes
Providing adequate analgesia during burn wound care is essential to patient-centered care. Both oral and intravenous (IV) ketamine are often used for analgesia and sedation. Ketami...

Back to Top